2-substituted 1-arylpiperazines as tachykinin antagonists...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S393000

Reexamination Certificate

active

10486479

ABSTRACT:
The present invention relates to piperazine of formula (I)whereinR represents halogen, C1-4alkyl, trifluoromethoxy or trifluoromethyl;R1is trifluoromethyl, C1-4alkyl, C1-4alkoxy, halogen or trifluoromethoxy;R2is hydrogen, C1-4alkyl or C2-6alkenyl;R3represents hydrogen or C1-4alkyl;n and m are independently 0 or an integer from 1 to 3;and pharmaceutically acceptable salts and solvates thereof, process for their preparation and their use in the treatment of condition mediated by tachykinins and/or by selective inhibition of the serotonin reuptake transporter protein.

REFERENCES:
patent: 5607936 (1997-03-01), Yuan-Ching et al.
patent: 5880128 (1999-03-01), Doll et al.
patent: 6642240 (2003-11-01), Alvaro et al.
patent: 0 464 604 (1992-01-01), None
patent: WO-9525443 (1995-09-01), None
patent: WO-9631501 (1996-10-01), None
patent: WO-9723466 (1997-07-01), None
patent: WO-9846626 (1998-10-01), None
patent: WO-9846627 (1998-10-01), None
patent: WO 01 25219 (2001-04-01), None
patent: WO 01/25219 (2001-04-01), None
patent: WO 02/32867 (2002-04-01), None
Ohnmacht et al. in Annual Reports in Medicinal Chemistry, vol. 33, p. 71-80 (1998).
Robichaud et al. in Annual Reports in Medicinal Chemistry, vol. 35, p. 11-20 (2000).
Vippagunta et al. Advanced Drug Delivery Reviews, vol. 48, p. 3-26 (2001).
Tamiz, A.P., et al. “A Convenient Procedure for the Synthesis of Nonsymmetrical Bivalent Selective Seronine Reuptake Inhibitors Using Polymer-Supported Reagents.” Biorg. Med. Chem. Lett., vol. 10, No. 24, 2000, pp. 2741-2744.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-substituted 1-arylpiperazines as tachykinin antagonists... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-substituted 1-arylpiperazines as tachykinin antagonists..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted 1-arylpiperazines as tachykinin antagonists... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3730619

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.